Fertility News and Research

RSS

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee has advised that the data presented support an indication for GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer and anal intraepithelial neoplasia (AIN) in both males and females 9 through 26 years of age.

18 Nov 2010

8 states get better grade on 2010 March of Dimes Premature Birth Report Card

Eight states earned a better grade on the 2010 March of Dimes Premature Birth Report Card and 32 others and the District of Columbia saw their preterm birth rates improve.

17 Nov 2010

Pre-term births are leading cause of health problems in infants and cost the U.S. over $26 billion annually

The Center for Healthcare Research & Transformation (CHRT) based at the University of Michigan today released its Prematurity Issue Brief that shows pre-term births --- births at less than 37 weeks of gestation --- are the leading cause of health problems in infants and estimated to cost the U.S. more than $26 billion annually. In addition, the report shows that a black infant in Michigan is 70% more likely to be born prematurely than an infant of any other race.

17 Nov 2010

Reproductive health forum in Ghana addresses unsafe abortions in Africa

The issue of unsafe abortion and its role in women's health was the focus of a four-day conference this week in Accra, Ghana, involving health experts, policymakers and health workers from across Africa, Ghana News Agency reports.

15 Nov 2010

Oregon scientist investigates safety, effectiveness of novel low-cost family-planning option

The Bill & Melinda Gates Foundation has awarded nationally prominent Oregon Health & Science University reproductive scientist Jeffrey T. Jensen, M.D., M.P.H., a $100,000 grant to investigate the safety and effectiveness of a novel low-cost family-planning option that may be applicable to women in low-resource countries worldwide.

15 Nov 2010

Hormones and stress are major contributors to depression in women who undergo IVF

Between 20 and 30 percent of women who undergo in vitro fertilization (IVF) procedures suffer from significant symptoms of depression. Many practitioners believe that the hormone therapy involved in IVF procedures is primarily responsible for this. But new research from Tel Aviv University shows that, while this is true, other factors are even more influential.

10 Nov 2010

Contraceptive, antiviral gel using bee venom wins 2010 Gates Foundation grant

A vaginal gel that affords both contraception and HIV protection using nanoparticles that carry bee venom is one of the bold, unconventional ideas that won a 2010 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation.

10 Nov 2010

GOP claims Statehouse victories that could set back health law implementation

"The Democrats' ambitious health care overhaul is facing roadblocks from newly elected state officials who harshly criticized it while campaigning and who are now in a position to make good on their promises," Kaiser Health News reports. The GOP made significant political gains in Tuesday's election, taking "Governors' mansions in several states." Among the newly elected governors were Sam Brownback of Kansas, "who called the reform law 'an abomination,'" and Tennessee's Bill Haslam, who called the law "an 'intolerable expansion' of federal power."

4 Nov 2010

Cerebral palsy risk doubles with IVF: Study

There is now evidence that rates of cerebral palsy are higher among children born via in vitro fertilization (IVF). There has been speculation that the parents’ infertility could be a reason but this new study is the first that links the procedure to the condition.

3 Nov 2010

Study finds infertility treatment does not increase risk of cerebral palsy in IVF/ICSI children

Doctors have known for some time that children born after fertility treatments such as in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) are at increased risk of cerebral palsy. However, it was not known whether this risk was due to the treatment itself, the higher frequency of preterm or multiple births, or a mechanism associated with couples' underlying infertility.

3 Nov 2010

CONRAD receives $5 million award from USAID

CONRAD, leaders in reproductive health and HIV prevention research, today announced a $5 million award from the US Agency for International Development (USAID). The grant will fund research and development of vaginal rings that are contraceptive and also prevent HIV and STI infections.

3 Nov 2010

Vitrolife operating income increases 3% to SEK 25 million for January to September 2010

Vitrolife: Growth in local currency was 13 percent. Sales amounted to SEK 217 (207) million, corresponding to an increase of 4 percent in SEK. Operating income before research and development costs increased by 11 percent and amounted to SEK 58 (53) million.

2 Nov 2010

GSN closes $12M Series C financing

Gene Security Network, Inc. today announced the closing of its $12M Series C financing. The financing round was led by Sequoia Capital and included Claremont Creek Ventures, Founders Fund, and Lightspeed Venture Partners.

2 Nov 2010

Women with type O blood linked to low egg numbers

In a study presented earlier this week at the American Society of Reproductive Medicine Conference in Denver, researchers at Yale and Albert Einstein College of Medicine measured levels of a chemical called follicle-stimulating hormone (FSH) in 560 women undergoing fertility treatments and found that those women with type O blood had chemical signs linked to low egg numbers.

30 Oct 2010

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

An endocrinologist in the University at Buffalo's School of Medicine and Biomedical Sciences has received a three-year $400,000 Junior Faculty Award from the American Diabetes Society to study the effects of low testosterone levels in young men with type 2 diabetes.

30 Oct 2010

Merck reports $342 million net income for 2010 third quarter

Merck & Co., Inc. today announced financial results for the third quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the third quarter of $0.85, which excludes purchase accounting adjustments, restructuring costs, merger-related expenses and a $950 million legal reserve.

29 Oct 2010

Research on sheep population could help explain variation in vaccine protection

Strong immunity may play a key role in determining long life, but may do so at the expense of reduced fertility, a Princeton University study has concluded.

29 Oct 2010

Parasitic disease inflicts damage to women's reproductive organs: Research

Faculty of Life Sciences at the University of Copenhagen shows that the parasitic disease, commonly known as snail fever, or schistosomiasis, almost eats its way into women's reproductive organs. Today researchers from all over the world are gathering in Copenhagen to find out what can be done to halt the disease which is affecting millions of women in Africa.

29 Oct 2010

Slivers of frozen ovaries allow for childbirth later in life

According a US fertility expert, young women should freeze parts of their ovaries if they want to postpone motherhood until later in life. This advice came from Dr Sherman Silber at the American Society for Reproductive Medicine meeting in Denver.

28 Oct 2010

CECOLFES fertility treatment results demonstrate effectiveness of INVOcell cycle process

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced today that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOLFES LTDA) in Bogota, Colombia presented the results of the Center's first 95 fertility treatment cycles utilizing INVO Bioscience's INVOcell for couples with fertility issues at the 66th Annual Meeting of the American Society of Reproductive Medicine (ASRM) in Denver.

28 Oct 2010

Fertility News and Research

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

8 states get better grade on 2010 March of Dimes Premature Birth Report Card

Pre-term births are leading cause of health problems in infants and cost the U.S. over $26 billion annually

Reproductive health forum in Ghana addresses unsafe abortions in Africa

Oregon scientist investigates safety, effectiveness of novel low-cost family-planning option

Hormones and stress are major contributors to depression in women who undergo IVF

Contraceptive, antiviral gel using bee venom wins 2010 Gates Foundation grant

GOP claims Statehouse victories that could set back health law implementation

Cerebral palsy risk doubles with IVF: Study

Study finds infertility treatment does not increase risk of cerebral palsy in IVF/ICSI children

CONRAD receives $5 million award from USAID

Vitrolife operating income increases 3% to SEK 25 million for January to September 2010

GSN closes $12M Series C financing

Women with type O blood linked to low egg numbers

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

Merck reports $342 million net income for 2010 third quarter

Research on sheep population could help explain variation in vaccine protection

Parasitic disease inflicts damage to women's reproductive organs: Research

Slivers of frozen ovaries allow for childbirth later in life

CECOLFES fertility treatment results demonstrate effectiveness of INVOcell cycle process

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News